Icotrokinra (JNJ2113) is an oral, first-in-class, anti-inflammatory biologic drug candidate and an interleukin-23 (IL-23) receptor antagonist peptide developed for the treatment of immune-mediated diseases like psoriasis.
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea